PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Jan-2026 Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes Businesswire
06-Jan-2026 3T Biosciences Announces Appointments of Behzad Kharabi, M.D., as Chief Medical Officer, and Parker Institute for Cancer Immunotherapy (PICI) CEO Karen Knudsen, MBA, Ph.D., to Board of Directors Businesswire
06-Jan-2026 Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes Businesswire
06-Jan-2026 Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens Businesswire
06-Jan-2026 Viridian Therapeutics Prepares for Transformational 2026 Businesswire
06-Jan-2026 SpliceBio Appoints Don Munoz as Chief Financial Officer Businesswire
06-Jan-2026 Newleos Therapeutics Announces Dosing of First Participant in SOAR Phase 2 Study of NTX-1472 for Social Anxiety Disorder Businesswire
06-Jan-2026 Lysoway Therapeutics Announces Phase I Readiness of Brain-Penetrant TRPML1 Agonist LW-1017 and Nomination of a TMEM175 Development Candidate Businesswire
06-Jan-2026 OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead’s Drug Candidate Businesswire
06-Jan-2026 Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360 Businesswire
06-Jan-2026 Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines Businesswire
06-Jan-2026 Ikarovec to Advance Pipeline With Exclusive Worldwide Option to VectorBuilder’s Intravitreal Capsid Technology Businesswire
06-Jan-2026 Iksuda to Present Preliminary Analysis of Oesophageal Cancer Data From Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium Businesswire
06-Jan-2026 Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 Businesswire
06-Jan-2026 Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference Businesswire
06-Jan-2026 Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026 Businesswire
05-Jan-2026 Hon. Judith N. McMahon (Ret.) Joins NAM’s Esteemed Panel of Neutrals Businesswire
05-Jan-2026 Bleichmar Fonti & Auld LLP Announces New Partners Businesswire
05-Jan-2026 Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan’s 44th Annual Healthcare Conference Businesswire
05-Jan-2026 SpineGuard Announces its 2026 Financial Calendar Businesswire